Safety and efficacy of stereotactic radioablation targeting pulmonary vein tissues in an experimental model


      Stereotactic radioablation (SR), a commonly used therapy to treat malignant tumors, has been used to treat refractory ventricular tachycardia, but the feasibility of treating atrial fibrillation with SR is unknown.


      We evaluated the safety and efficacy of SR targeting pulmonary vein (PV) antral tissues as a potential therapy for atrial fibrillation.


      Seventeen adult canines and 2 adult swine underwent surgical fiducial marker placement, 3-dimensional anatomic rendering computed tomography angiogram of the left atrium, and creation of a treatment plan targeting the right superior PVs. Four treatment doses (15, 20, 25, and 35 Gy) were administered to 4 cohorts. Subjects were monitored for 3–6 months, followed by electrophysiological testing, gross pathological examination, and histopathology in 2 subjects.


      All subjects received SR treatment without complication. Electrophysiology study and gross pathological analysis demonstrated treatment effect in all treated PVs at 35 Gy and 25 Gy (n = 11 of 11 [100%]), with a partial effect at 20 Gy (n = 4 of 5 [80%]; 1 did not undergo repeat electrophysiology study) and 15 Gy (n = 1 of 2 [50%]). No evidence of collateral injury was found in tissues directly adjacent to the treated PVs. In 2 subjects, detailed histopathology demonstrated evidence of circumferential, transmural scar at the PV ablation sites, with sparing of the surrounding structures.


      SR is safe and effective for creating precise circumferential scar and electrical isolation of the right superior PV in an experimental model, with dose dependence between delivered radioablative energy and observed electrical effects.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Calkins H.
        • Hindricks G.
        • Cappato R.
        • et al.
        2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.
        Heart Rhythm. 2017; 14: e275-e444
        • Leskell L.
        The stereotaxic method and radiosurgery of the brain.
        Act Chir Scand. 1951; 102: 316-319
        • Macià I.
        • Garau M.
        Radiobiology of stereotactic body radiation therapy (SBRT).
        Rep Pract Oncol Radiother. 2017; 22: 86-95
        • Lettmaier S.
        Radiosurgery in trigeminal neuralgia.
        Phys Med. 2014; 30: 592-595
        • Haasbeek C.J.
        • Lagerwaard F.J.
        • Slotman B.J.
        • et al.
        Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer.
        J Thorac Oncol. 2011; 6: 2036-2043
        • Chaudhuri A.A.
        • Tang C.
        • Binkley M.S.
        • Jin M.
        • Wynne J.F.
        • von Eyben R.
        • Hara W.Y.
        • Trakul N.
        • Loo Jr., B.W.
        • Diehn M.
        Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors.
        Lung Cancer. 2015; 89: 50-56
        • Soltys S.G.
        • Kalani M.Y.
        • Cheshier S.H.
        • Szabo K.A.
        • Lo A.
        • Chang S.D.
        Stereotactic radiosurgery for a cardiac sarcoma: a case report.
        Technol Cancer Res Treat. 2008; 7: 363-368
        • Sharma A.
        • Wong D.
        • Weidlich G.
        • Fogarty T.
        • Jack A.
        • Sumanaweera T.
        • Maguire P.
        Noninvasive stereotactic radiosurgery (CyberHeart) for creation of ablation lesions in the atrium.
        Heart Rhythm. 2010; 7: 802-810
        • Loo Jr., B.W.
        • Soltys S.G.
        • Wang L.
        • Lo A.
        • Fahimian B.P.
        • Iagaru A.
        • Norton L.
        • Shan X.
        • Gardner E.
        • Fogarty T.
        • Maguire P.
        • Al-Ahmad A.
        • Zei P.
        Stereotactic ablative radiotherapy for the treatment of refractory cardiac ventricular arrhythmia.
        Circ Arrhythm Electrophysiol. 2015; 8: 748-750
        • Zei P.C.
        • Soltys S.
        Ablative radiotherapy as a noninvasive alternative to catheter ablation for cardiac arrhythmias.
        Curr Cardiol Rep. 2017; 19: 79-84
        • Cuculich P.S.
        • Schill M.R.
        • Kashani R.
        • et al.
        Noninvasive cardiac radiation for ablation of ventricular tachycardia.
        N Engl J Med. 2017; 377: 2325-2336
      1. Benirschke K, Garner FM, Jones TC (eds). Pericardial defects. In: Pathology of Laboratory Animals. 1st ed., vol 1. New York: Springer; 1978:47.

        • Winter J.D.
        • Wong R.
        • Swaminath A.
        • Chow T.
        Accuracy of robotic radiosurgical liver treatment throughout the respiratory cycle.
        Int J Radiat Oncol Biol Phys. 2015; 93: 916-924
        • Brown J.M.
        • Carlson D.J.
        • Brenner D.J.
        The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?.
        Int J Radiat Oncol Biol Phys. 2014; 88: 254-262
        • Gardner E.A.
        • Weidlich G.A.
        Analysis of dose distribution in the heart for radiosurgical ablation of atrial fibrillation.
        Cureus. 2016; 8: e703
        • Bode F.
        • Blanck O.
        • Gebhard M.
        • Hunold P.
        • Grossherr M.
        • Brandt S.
        • Vonthein R.
        • Thiele H.
        • Dunst J.
        • Rades D.
        Pulmonary vein isolation by radiosurgery: implications for non-invasive treatment of atrial fibrillation.
        Europace. 2015; 17: 1868-1874
        • Adams M.J.
        • Lipshultz S.E.
        • Schwartz C.
        • Fajardo L.F.
        • Coen V.
        • Constine L.S.
        Radiation-associated cardiovascular disease: manifestations and management.
        Semin Radiat Oncol. 2003; 13: 346-356
        • Gagliardi G.
        • Constine L.S.
        • Moiseenko V.
        • Correa C.
        • Pierce L.J.
        • Allen A.M.
        • Marks L.B.
        Radiation dose-volume effects in the heart.
        Int J Radiat Oncol Biol Phys. 2010; 76: S77-S85
        • Lehmann H.I.
        • Graeff C.
        • Simoniello P.
        • et al.
        Feasibility study on cardiac arrhythmia ablation using high-energy heavy ion beams.
        Sci Rep. 2016; 6: 38895